Valneva Se Stock Net Income
| INRLF Stock | USD 4.85 0.10 2.11% |
As of the 16th of February 2026, Valneva SE has the Semi Deviation of 1.24, risk adjusted performance of 0.0398, and Coefficient Of Variation of 2481.91. Valneva SE technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Valneva SE jensen alpha, as well as the relationship between the potential upside and skewness to decide if Valneva SE is priced more or less accurately, providing market reflects its prevalent price of 4.85 per share. Given that Valneva SE has jensen alpha of 0.1082, we advise you to double-check Valneva SE's current market performance to make sure the company can sustain itself at a future point.
Valneva SE's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Valneva SE's valuation are provided below:Valneva SE does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Valneva |
Valneva SE 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Valneva SE's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Valneva SE.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Valneva SE on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Valneva SE or generate 0.0% return on investment in Valneva SE over 90 days. Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for i... More
Valneva SE Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Valneva SE's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Valneva SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.47 | |||
| Information Ratio | 0.0168 | |||
| Maximum Drawdown | 26.59 | |||
| Value At Risk | (3.52) | |||
| Potential Upside | 2.11 |
Valneva SE Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Valneva SE's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Valneva SE's standard deviation. In reality, there are many statistical measures that can use Valneva SE historical prices to predict the future Valneva SE's volatility.| Risk Adjusted Performance | 0.0398 | |||
| Jensen Alpha | 0.1082 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0145 | |||
| Treynor Ratio | 3.51 |
Valneva SE February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0398 | |||
| Market Risk Adjusted Performance | 3.52 | |||
| Mean Deviation | 1.0 | |||
| Semi Deviation | 1.24 | |||
| Downside Deviation | 3.47 | |||
| Coefficient Of Variation | 2481.91 | |||
| Standard Deviation | 2.98 | |||
| Variance | 8.89 | |||
| Information Ratio | 0.0168 | |||
| Jensen Alpha | 0.1082 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.0145 | |||
| Treynor Ratio | 3.51 | |||
| Maximum Drawdown | 26.59 | |||
| Value At Risk | (3.52) | |||
| Potential Upside | 2.11 | |||
| Downside Variance | 12.04 | |||
| Semi Variance | 1.54 | |||
| Expected Short fall | (4.85) | |||
| Skewness | 5.27 | |||
| Kurtosis | 37.92 |
Valneva SE Backtested Returns
Valneva SE appears to be slightly risky, given 3 months investment horizon. Valneva SE owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.066, which indicates the firm had a 0.066 % return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Valneva SE, which you can use to evaluate the volatility of the company. Please review Valneva SE's Semi Deviation of 1.24, risk adjusted performance of 0.0398, and Coefficient Of Variation of 2481.91 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Valneva SE holds a performance score of 5. The entity has a beta of 0.0314, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Valneva SE's returns are expected to increase less than the market. However, during the bear market, the loss of holding Valneva SE is expected to be smaller as well. Please check Valneva SE's potential upside, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Valneva SE's existing price patterns will revert.
Auto-correlation | -0.28 |
Weak reverse predictability
Valneva SE has weak reverse predictability. Overlapping area represents the amount of predictability between Valneva SE time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Valneva SE price movement. The serial correlation of -0.28 indicates that nearly 28.0% of current Valneva SE price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.28 | |
| Spearman Rank Test | -0.14 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Valneva SE reported net income of (73.42 Million). This is 121.51% lower than that of the Healthcare sector and 204.82% lower than that of the Biotechnology industry. The net income for all United States stocks is 112.86% higher than that of the company.
Valneva Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Valneva SE's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Valneva SE could also be used in its relative valuation, which is a method of valuing Valneva SE by comparing valuation metrics of similar companies.Valneva SE is currently under evaluation in net income category among its peers.
Valneva Fundamentals
| Return On Equity | -1.86 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 880.26 M | |||
| Shares Outstanding | 138.22 M | |||
| Shares Owned By Insiders | 17.56 % | |||
| Shares Owned By Institutions | 21.62 % | |||
| Price To Earning | (4.57) X | |||
| Price To Book | 5.63 X | |||
| Price To Sales | 2.23 X | |||
| Revenue | 348.08 M | |||
| Gross Profit | (13.12 M) | |||
| EBITDA | (38.73 M) | |||
| Net Income | (73.42 M) | |||
| Cash And Equivalents | 336.22 M | |||
| Cash Per Share | 2.87 X | |||
| Total Debt | 50.73 M | |||
| Debt To Equity | 1.43 % | |||
| Current Ratio | 1.15 X | |||
| Book Value Per Share | 1.56 X | |||
| Cash Flow From Operations | 76.9 M | |||
| Earnings Per Share | 0.90 X | |||
| Number Of Employees | 762 | |||
| Beta | 0.99 | |||
| Market Capitalization | 944.39 M | |||
| Total Asset | 817.35 M | |||
| Retained Earnings | (546.27 M) | |||
| Working Capital | 48.89 M | |||
| Current Asset | 89.75 M | |||
| Current Liabilities | 40.86 M | |||
| Z Score | 10.8 | |||
| Net Asset | 817.35 M |
About Valneva SE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Valneva SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Valneva SE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Valneva SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Valneva Pink Sheet
Valneva SE financial ratios help investors to determine whether Valneva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valneva with respect to the benefits of owning Valneva SE security.